Bank of Montreal
VRNA

Bank of Montreal’s Verona Pharma VRNA Stock Holding History

Bank of Montreal’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-85,141
Closed -$8.05M – 3823
2025
Q2 		$8.05M Buy
85,141
+76,472
+882% +$5.66M ﹤0.01% 1070
2025
Q1 		$550K Buy
+8,669
New +$519K ﹤0.01% 2137
2023
Q3 		– Sell
-10,000
Closed -$217K – 4266
2023
Q2 		$217K Sell
10,000
-12,000
-55% -$256K ﹤0.01% 3181
2023
Q1 		$443K Buy
+22,000
New +$475K ﹤0.01% 2529

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's VRNA Position: Q3 2025 in Review

Bank of Montreal sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 85,141 shares — an estimated $8.05M sold.

Bank of Montreal first reported a position in VRNA in Q1 2023 and held it in 4 quarters. The position peaked at $8.05M in Q2 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • Bank of Montreal reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 85,141 Verona Pharma shares in Q3 2025, an estimated $8.05M.
  • Bank of Montreal first reported a position in Verona Pharma in Q1 2023 and held it in 4 quarters.
  • Bank of Montreal's Verona Pharma position peaked at $8.05M in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.